A

Anchiano Therapeutics

2 employees

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Therapy
immunotherapy
RAS
Cancer
Medical Device
Target Therapy
Health Care
Oncology
Pan-RAS
Bladder Cancer

Date founded

2004

Funding rounds raised

Total raised

$23M

from 2 investors over 2 rounds

A

Anchiano Therapeutics raised $23M on April 13, 2018

Investors: Clal Biotechnology Industries

A

Anchiano Therapeutics raised undisclosed on March 1, 2010

Investors: Cybele Holdings

FAQ